The patient's inability to comply with the protocol in opinion of the Investigator 1. Intake of any experimental anti-COVID-19 study drugs 2. Intake of any plasma therapy, in particular plasma therapy with COVID-19 convalescents 3. Infection with human immunodeficiency virus (HIV) 4. Pregnancy or breastfeeding 5.All conditions that the doctor qualifying for the study considers harmful to the patient participating in this study, including any clinically significant deviations from normal clinical laboratory values ​​or concurrent medical events or situations that prevent the proper performance of the study (e.g. insufficient knowledge of the Polish language by the patient in the opinion of the researcher) 6. Participation in another interventional clinical trial in the last 30 days.

The patient's inability to comply with the protocol in opinion of the Investigator 1. Intake of any experimental anti-COVID-19 study drugs 2. Intake of any plasma therapy, in particular plasma therapy with COVID-19 convalescents 3. Infection with human immunodeficiency virus (HIV) 4. Pregnancy or breastfeeding 5.All conditions that the doctor qualifying for the study considers harmful to the patient participating in this study, including any clinically significant deviations from normal clinical laboratory values ​​or concurrent medical events or situations that prevent the proper performance of the study (e.g. insufficient knowledge of the Polish language by the patient in the opinion of the researcher) 6. Participation in another interventional clinical trial in the last 30 days.